| Product NDC: | 0187-0003 |
| Proprietary Name: | CAPITAL AND CODEINE |
| Non Proprietary Name: | Acetaminophen and codeine phosphate |
| Active Ingredient(s): | 120; 12 mg/5mL; mg/5mL & nbsp; Acetaminophen and codeine phosphate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0187-0003 |
| Labeler Name: | Valeant Pharmaceuticals International |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA086024 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040503 |
| Package NDC: | 0187-0003-01 |
| Package Description: | 473 mL in 1 BOTTLE (0187-0003-01) |
| NDC Code | 0187-0003-01 |
| Proprietary Name | CAPITAL AND CODEINE |
| Package Description | 473 mL in 1 BOTTLE (0187-0003-01) |
| Product NDC | 0187-0003 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Acetaminophen and codeine phosphate |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20040503 |
| Marketing Category Name | ANDA |
| Labeler Name | Valeant Pharmaceuticals International |
| Substance Name | ACETAMINOPHEN; CODEINE PHOSPHATE |
| Strength Number | 120; 12 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes |